Note: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. For more information about sustainable investment labels, please see the FCA page linked here.
Global Equity Index Management (GE)
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 31 Dec 2025
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 404 | 390 | 31 Dec 2025 |
| Median market capital | 57.8 B | 70.7 B | 31 Dec 2025 |
| 17.2 x | 17.2 x | 31 Dec 2025 | |
| 2.4 x | 2.4 x | 31 Dec 2025 | |
| 13.1% | 13.1% | 31 Dec 2025 | |
| 14.3% | 14.3% | 31 Dec 2025 | |
| Portfolio turnover rate | -18.0% | — | 31 Dec 2025 |
As at 31 Dec 2025
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 18.81% | 18.78% | 0.03% |
| Switzerland | Europe | 17.40% | 17.40% | 0.00% |
| Germany | Europe | 15.60% | 15.61% | -0.01% |
| France | Europe | 9.88% | 10.47% | -0.59% |
| Netherlands | Europe | 9.52% | 9.52% | 0.00% |
| Sweden | Europe | 6.41% | 6.41% | 0.00% |
| Spain | Europe | 5.86% | 5.86% | 0.00% |
| Italy | Europe | 5.43% | 5.43% | 0.00% |
| Denmark | Europe | 3.75% | 3.75% | 0.00% |
| Finland | Europe | 1.84% | 1.85% | -0.01% |
| Belgium | Europe | 1.73% | 1.73% | 0.00% |
| Norway | Europe | 0.85% | 0.85% | 0.00% |
| Ireland | Europe | 0.78% | 0.78% | 0.00% |
| Poland | Europe | 0.74% | 0.73% | 0.01% |
| Austria | Europe | 0.61% | 0.61% | 0.00% |
As at 31 Dec 2025
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.34122% | Technology | NL | €27,406,121.60 | 29,744 |
| Roche Holding AG | 2.96918% | Health Care | CH | €18,744,398.50 | 53,141 |
| AstraZeneca PLC | 2.83356% | Health Care | GB | €17,888,243.63 | 113,266 |
| Novartis AG | 2.70654% | Health Care | CH | €17,086,356.40 | 145,056 |
| SAP SE | 2.56397% | Technology | DE | €16,186,294.80 | 77,688 |
| Nestle SA | 2.56248% | Consumer Staples | CH | €16,176,912.70 | 191,160 |
| Siemens AG | 2.10182% | Industrials | DE | €13,268,759.45 | 55,483 |
| Allianz SE | 1.80522% | Financials | DE | €11,396,352.00 | 29,184 |
| Banco Santander SA | 1.78741% | Financials | ES | €11,283,908.29 | 1,120,547 |
| Novo Nordisk A/S | 1.66096% | Health Care | DK | €10,485,641.80 | 240,792 |
-
Inception date
06 Dec 2013
| Date | NAV (EUR) |
|---|---|
| 16 Jan 2026 | €261.2877 |
| 15 Jan 2026 | €261.5069 |
| 14 Jan 2026 | €260.6546 |
| 13 Jan 2026 | €259.5885 |
| 12 Jan 2026 | €260.1009 |
| 09 Jan 2026 | €259.6248 |
| 08 Jan 2026 | €257.8134 |
| 07 Jan 2026 | €257.5483 |
| 06 Jan 2026 | €257.8603 |
| 05 Jan 2026 | €256.0697 |
Distribution frequency
—
Historical performance 31 Dec 2025
2.87%
All dividends are reinvested for the "Accumulation" shares.
Base currency: EUR